These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1663043)

  • 1. Effects of four diltiazem stereoisomers on binding of d-cis-[3H]diltiazem and (+)-[3H]PN200-110 to rabbit T-tubule calcium channels.
    Ikeda S; Oka J; Nagao T
    Eur J Pharmacol; 1991 Nov; 208(3):199-205. PubMed ID: 1663043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-affinity binding of DTZ323, a novel derivative of diltiazem, to rabbit skeletal muscle L-type Ca++ channels.
    Hagiwara M; Adachi-Akahane S; Nagao T
    J Pharmacol Exp Ther; 1997 Apr; 281(1):173-9. PubMed ID: 9103495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of diltiazem and verapamil on (+)-PN 200-110 binding kinetics in dog cardiac membranes.
    Miwa K; Miyagi Y; Araie E; Sasayama S
    Eur J Pharmacol; 1992 Apr; 214(2-3):127-32. PubMed ID: 1325351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium ions inhibit the allosteric interaction between the dihydropyridine and phenylalkylamine binding site on the voltage-gated calcium channel in heart sarcolemma but not in skeletal muscle transverse tubules.
    Murphy BJ; Tuana BS
    Can J Physiol Pharmacol; 1990 Nov; 68(11):1389-95. PubMed ID: 1962734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric interaction of semotiadil fumarate, a novel benzothiazine, with 1,4-dihydropyridines, phenylalkylamines, and 1,5-benzothiazepines at the Ca(2+)-channel antagonist binding sites in canine skeletal muscle membranes.
    Nakayama K; Nozawa Y; Fukuta Y
    J Cardiovasc Pharmacol; 1994 May; 23(5):731-40. PubMed ID: 7521455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding characteristics of a new 1,5-benzothiazepine, clentiazem, to rat cerebral cortex and skeletal muscle membranes.
    Suzuki T; Kurosawa H; Naito K; Otsuka M; Ohashi M; Takaiti O
    Eur J Pharmacol; 1991 Mar; 194(2-3):195-200. PubMed ID: 2060600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bis(benzylisoquinoline) analogs of tetrandrine block L-type calcium channels: evidence for interaction at the diltiazem-binding site.
    Felix JP; King VF; Shevell JL; Garcia ML; Kaczorowski GJ; Bick IR; Slaughter RS
    Biochemistry; 1992 Dec; 31(47):11793-800. PubMed ID: 1332772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive heterotropic allosteric regulators of dihydropyridine binding increase the Ca2+ affinity of the L-type Ca2+ channel. Stereoselective reversal by the novel Ca2+ antagonist BM 20.1140.
    Staudinger R; Knaus HG; Glossmann H
    J Biol Chem; 1991 Jun; 266(17):10787-95. PubMed ID: 1645709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and photoaffinity labeling of receptor sites for the Ca2+ channel inhibitors d-cis-diltiazem, (+/-)-bepridil, desmethoxyverapamil, and (+)-PN 200-110 in skeletal muscle transverse tubule membranes.
    Galizzi JP; Borsotto M; Barhanin J; Fosset M; Lazdunski M
    J Biol Chem; 1986 Jan; 261(3):1393-7. PubMed ID: 3003067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photoaffinity labeling of the purified skeletal muscle calcium antagonist receptor by a novel benzothiazepine, [3H]azidobutyryl diltiazem.
    Naito K; McKenna E; Schwartz A; Vaghy PL
    J Biol Chem; 1989 Dec; 264(35):21211-4. PubMed ID: 2556399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin binds with high affinity to voltage-dependent L-type Ca2+ channels. Evidence for an agonistic action.
    Knaus HG; Scheffauer F; Romanin C; Schindler HG; Glossmann H
    J Biol Chem; 1990 Jul; 265(19):11156-66. PubMed ID: 2162834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-affinity binding of [3H]DTZ323 to the diltiazem-binding site of L-type Ca2+ channels.
    Hagiwara M; Adachi-Akahane S; Nagao T
    Eur J Pharmacol; 2003 Apr; 466(1-2):63-71. PubMed ID: 12679142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding Ca2+ to intracellular or to extracellular sites of dihydropyridine receptor of rabbit skeletal muscle discriminates between in vitro binding of Ca2+-channel agonist and antagonist.
    Kanngiesser U; Pongs O
    Eur J Biochem; 1989 May; 181(2):467-73. PubMed ID: 2540975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.
    Nokin P; Clinet M; Beaufort P; Meysmans L; Laruel R; Chatelain P
    J Pharmacol Exp Ther; 1990 Nov; 255(2):600-7. PubMed ID: 2147036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification, characterization, and photoaffinity labeling of the dihydropyridine receptor associated with the L-type calcium channel from bovine adrenal medulla.
    Murphy BJ; Rogers CA; Sunahara RK; Lemaire S; Tuana BS
    Mol Pharmacol; 1990 Feb; 37(2):173-81. PubMed ID: 2154669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temperature-dependent regulation of d-cis-[3H]diltiazem binding to Ca2+ channels by 1,4-dihydropyridine channel agonists and antagonists.
    Glossmann H; Linn T; Rombusch M; Ferry DR
    FEBS Lett; 1983 Aug; 160(1-2):226-32. PubMed ID: 6309565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purified calcium channels have three allosterically coupled drug receptors.
    Striessnig J; Goll A; Moosburger K; Glossmann H
    FEBS Lett; 1986 Mar; 197(1-2):204-10. PubMed ID: 2419161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of Ca2+ entry blockers to cardiac sarcolemmal membrane vesicles. Characterization of diltiazem-binding sites and their interaction with dihydropyridine and aralkylamine receptors.
    Garcia ML; King VF; Siegl PK; Reuben JP; Kaczorowski GJ
    J Biol Chem; 1986 Jun; 261(18):8146-57. PubMed ID: 2424894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydropyridine receptor of L-type Ca2+ channels: identification of binding domains for [3H](+)-PN200-110 and [3H]azidopine within the alpha 1 subunit.
    Striessnig J; Murphy BJ; Catterall WA
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10769-73. PubMed ID: 1660150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of binding of dihydropyridine calcium channel ligands to skeletal muscle membranes: evidence for low-affinity sites and for the involvement of G proteins.
    Dunn SM; Bladen C
    Biochemistry; 1991 Jun; 30(23):5716-21. PubMed ID: 1645998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.